Senescent cells as a source of inflammatory factors for tumor progression
暂无分享,去创建一个
Judith Campisi | J. Campisi | Jean-Philippe Coppé | P. Desprez | Pierre-Yves Desprez | Albert R. Davalos | Jean-Philippe Coppe | Jean-Philippe Coppé
[1] D. Roeder,et al. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. , 1990, Science.
[2] P. Hornsby,et al. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. , 2007, Cancer research.
[3] H. Huttunen,et al. Regulation of cell migration by amphoterin. , 2000, Journal of cell science.
[4] N. Sharpless,et al. Ink4a/Arf expression is a biomarker of aging. , 2004, The Journal of clinical investigation.
[5] P. Fisher,et al. Modulating T cell signals using CD3/CD28 Xcyte™ Dynabeads® allows for selective expansion or deletion of antigen-specific T cells , 2004 .
[6] M. Feldmann,et al. Cytokine expression in chronic inflammatory disease. , 1995, British medical bulletin.
[7] M. Narita,et al. SASP reflects senescence , 2009, EMBO reports.
[8] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[9] J. Campisi,et al. Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.
[10] Jonathan Melamed,et al. Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.
[11] C. Baglioni,et al. Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[13] K. Camphausen,et al. Radiation therapy to a primary tumor accelerates metastatic growth in mice. , 2001, Cancer research.
[14] D. Terrian,et al. Senescence-associated exosome release from human prostate cancer cells. , 2008, Cancer research.
[15] Judith Campisi,et al. Cancer and ageing: rival demons? , 2003, Nature Reviews Cancer.
[16] S. Lowe,et al. Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.
[17] Robert D. Cardiff,et al. Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.
[18] S. Lowe,et al. Senescence of Activated Stellate Cells Limits Liver Fibrosis , 2008, Cell.
[19] P. Chiao,et al. Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells. , 2004, The Journal of biological chemistry.
[20] J. Campisi,et al. Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence* , 2006, Journal of Biological Chemistry.
[21] M. Serrano,et al. The power and the promise of oncogene-induced senescence markers , 2006, Nature Reviews Cancer.
[22] P. Claudio,et al. Molecular basis of angiogenesis and cancer , 2003, Oncogene.
[23] E. Abraham,et al. HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines1 , 2008, The Journal of Immunology.
[24] C. Schmitt,et al. Oncogene-induced senescence: putting the brakes on tumor development. , 2006, Cancer research.
[25] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[26] K. Ohuchida,et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. , 2004, Cancer research.
[27] J. Bridger,et al. Alterations to Nuclear Architecture and Genome Behavior in Senescent Cells , 2007, Annals of the New York Academy of Sciences.
[28] N. Holbrook,et al. Oxidants, oxidative stress and the biology of ageing , 2000, Nature.
[29] J. Hiscott,et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.
[30] A. Zlotnik,et al. Chemokines: agents for the immunotherapy of cancer? , 2002, Nature Reviews Immunology.
[31] M. Narita,et al. Cellular senescence and chromatin organisation , 2007, British Journal of Cancer.
[32] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[33] Kevin J. Tracey,et al. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.
[34] P. Adams. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. , 2007, Gene.
[35] I. Roninson,et al. Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. , 2004, Cancer research.
[36] Judith Campisi,et al. Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network , 2009, Proceedings of the National Academy of Sciences.
[37] G. Martin. Genetic Modulation of Senescent Phenotypes in Homo sapiens , 2005, Cell.
[38] J. Shay,et al. Cellular senescence as a tumor-protection mechanism: the essential role of counting. , 2001, Current opinion in genetics & development.
[39] P. Chiao,et al. Identification of an Autoregulatory Feedback Pathway Involving Interleukin-1α in Induction of Constitutive NF-κB Activation in Pancreatic Cancer Cells* , 2004, Journal of Biological Chemistry.
[40] R. Thweatt,et al. Characterization Of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts , 1996, Mechanisms of Ageing and Development.
[41] Manuel Serrano,et al. The common biology of cancer and ageing , 2007, Nature.
[42] H. Harris,et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. , 2003, Arthritis and rheumatism.
[43] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.
[44] M. Ikeda,et al. Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endothelial cell. , 1993, Biochemical and biophysical research communications.
[45] C Roskelley,et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[46] Li Fang,et al. Inhibition of p21‐mediated ROS accumulation can rescue p21‐induced senescence , 2002, The EMBO journal.
[47] I. Komuro,et al. Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p 21-Dependent Pathway , 2006 .
[48] U. Andersson,et al. RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.
[49] D. Schadendorf,et al. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.
[50] E. Block,et al. Senescence-enhanced oxidative stress is associated with deficiency of mitochondrial cytochrome c oxidase in vascular endothelial cells , 2003, Mechanisms of Ageing and Development.
[51] R. Derynck,et al. Effects of MGSA/GRO alpha on melanocyte transformation. , 1991, Oncogene.
[52] I. Komuro,et al. Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p21-Dependent Pathway , 2006, Circulation.
[53] D. Peeper,et al. Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.
[54] J. Ward,et al. Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells1 , 2001, The Journal of Immunology.
[55] Judith Campisi,et al. Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.
[56] T. Lüscher,et al. Enhanced Peroxynitrite Formation Is Associated with Vascular Aging , 2000, The Journal of experimental medicine.
[57] M. Barcellos-Hoff,et al. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.
[58] Š. Pospíšilová,et al. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops. , 2004, Biochemistry.
[59] F. Orr,et al. Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis. , 2001, Surgical oncology clinics of North America.
[60] A. J. Millis,et al. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. , 1992, Experimental cell research.
[61] S. Brod. Unregulated inflammation shortens human functional longevity , 2000, Inflammation Research.
[62] M. Benson,et al. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. , 2000, Urology.
[63] G. Zeng,et al. Differential regulation of collagenase and stromelysin mRNA in late passage cultures of human fibroblasts. , 1996, Experimental cell research.
[64] R. Weinberg,et al. The signals and pathways activating cellular senescence. , 2005, The international journal of biochemistry & cell biology.
[65] J. Campisi,et al. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.
[66] J. Wallace,et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.
[67] J. Campisi. Cellular senescence as a tumor-suppressor mechanism. , 2001, Trends in cell biology.
[68] W. Hornebeck,et al. Proteolyzed matrix as a template for the regulation of tumor progression. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[69] John M Sedivy,et al. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.
[70] Gordon J. Lithgow,et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8 , 2009, Aging.
[71] P. Nelson,et al. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. , 2006, Cancer research.
[72] P. Rogalla,et al. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. , 2005, The American journal of pathology.
[73] H. Lodish. Molecular Cell Biology , 1986 .
[74] Qin M. Chen,et al. Novel mechanisms of sublethal oxidant toxicity: induction of premature senescence in human fibroblasts confers tumor promoter activity. , 2003, Experimental cell research.
[75] J. R. Smith,et al. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. , 1989, Experimental cell research.
[76] D. Baltimore,et al. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.
[77] Alberto Mantovani,et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.
[78] D. Bar-Sagi,et al. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.
[79] V. Ferrans,et al. Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species* , 1999, The Journal of Biological Chemistry.
[80] M. Bianchi,et al. HMG proteins: dynamic players in gene regulation and differentiation. , 2005, Current opinion in genetics & development.
[81] M. Bianchi,et al. HMGB1 loves company , 2009, Journal of leukocyte biology.
[82] C. Berking,et al. Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8 , 2003, International journal of cancer.
[83] Michael R. Elliott,et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance , 2009, Nature.
[84] Jeen-Woo Park,et al. Expression of connective tissue growth factor, a biomarker in senescence of human diploid fibroblasts, is up-regulated by a transforming growth factor-beta-mediated signaling pathway. , 2004, Biochemical and biophysical research communications.
[85] A. Ben-Baruch. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. , 2006, Seminars in cancer biology.
[86] A. Ridley,et al. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. , 1998, Molecular biology of the cell.
[87] B. Foster,et al. Pharmacological rescue of mutant p53 conformation and function. , 1999, Science.
[88] Robert S. Balaban,et al. Mitochondria, Oxidants, and Aging , 2005, Cell.
[89] M. Burdick,et al. Cancer CXC chemokine networks and tumour angiogenesis. , 2006, European journal of cancer.
[90] I. Roninson,et al. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[91] J. Yates,et al. PRAK Is Essential for ras-Induced Senescence and Tumor Suppression , 2007, Cell.
[92] T. Jacks,et al. Restoration of p53 function leads to tumour regression in vivo , 2007, Nature.
[93] K. Chin,et al. A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen , 2010, PloS one.
[94] D. Ribatti,et al. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. , 2000, Blood.
[95] H. Rauvala,et al. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). , 2007, Journal of leukocyte biology.
[96] M. Herlyn,et al. Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells1 , 2001, The Journal of Immunology.
[97] J. McLachlan,et al. Immunological functions of aged human monocytes. , 1995, Pathobiology : journal of immunopathology, molecular and cellular biology.
[98] P. Carmeliet,et al. uPAR: a versatile signalling orchestrator , 2002, Nature Reviews Molecular Cell Biology.
[99] J. Little,et al. Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment. , 2005, Cancer research.
[100] F. D. D. Fagagna. Living on a break: cellular senescence as a DNA-damage response , 2008, Nature Reviews Cancer.
[101] Jessie C. Jeyapalan,et al. Accumulation of senescent cells in mitotic tissue of aging primates , 2007, Mechanisms of Ageing and Development.
[102] Frederick W. Alt,et al. DNA Repair, Genome Stability, and Aging , 2005, Cell.
[103] P. Adams. Remodeling chromatin for senescence , 2007, Aging cell.
[104] S. Bode-Böger,et al. Asymmetric dimethylarginine (ADMA) accelerates cell senescence , 2005, Vascular medicine.
[105] C. Franceschi,et al. Aging, Longevity, Inflammation, and Cancer , 2004, Annals of the New York Academy of Sciences.
[106] C. Schmitt. Senescence, apoptosis and therapy — cutting the lifelines of cancer , 2003, Nature Reviews Cancer.
[107] N. Carter,et al. A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.
[108] Shu-Chun Lin,et al. Ripe areca nut extract induces G1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. , 2006, Carcinogenesis.
[109] K. Wiman,et al. Reactivation of mutant p53: molecular mechanisms and therapeutic potential , 2007, Oncogene.
[110] J. Campisi,et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.
[111] M. Barbacid,et al. Tumour biology: Senescence in premalignant tumours , 2005, Nature.
[112] J. Campisi,et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[113] Kimi Yamakoshi,et al. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. , 2004, The journal of medical investigation : JMI.
[114] J. Campisi,et al. Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.
[115] C. Prives,et al. High mobility group protein-1 (HMG-1) is a unique activator of p53. , 1998, Genes & development.
[116] J. Campisi. Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.
[117] S. Plymate,et al. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. , 2000, Endocrinology.
[118] A. Frey. Myeloid suppressor cells regulate the adaptive immune response to cancer. , 2006, The Journal of clinical investigation.
[119] Carlos Cordon-Cardo,et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas , 2007, Nature.
[120] Edward G Lakatta,et al. Arterial aging: is it an immutable cardiovascular risk factor? , 2005, Hypertension.
[121] K. Chien,et al. Longevity and Lineages: Toward the Integrative Biology of Degenerative Diseases in Heart, Muscle, and Bone , 2005, Cell.
[122] G. Peters,et al. Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.
[123] T. Kislinger,et al. Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.
[124] P. Chène. Inhibiting the p53–MDM2 interaction: an important target for cancer therapy , 2003, Nature Reviews Cancer.
[125] F. Ishikawa,et al. Cellular senescence and chromatin structure , 2007, Chromosoma.
[126] H. Katinger,et al. Subtractive Hybridization of mRNA from early passage and senescent endothelial cells , 2000, Experimental Gerontology.
[127] A. Mantovani,et al. Chemokines in neoplastic progression. , 2004, Seminars in cancer biology.
[128] Feng Yang,et al. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. , 2005, Cancer research.
[129] J. Campisi,et al. A Role for Fibroblasts in Mediating the Effects of Tobacco-Induced Epithelial Cell Growth and Invasion , 2008, Molecular Cancer Research.
[130] S. Brown,et al. Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[131] D. Palmieri,et al. Age-related expression of PEDF/EPC-1 in human endometrial stromal fibroblasts: implications for interactive senescence. , 1999, Experimental cell research.
[132] B. Groner,et al. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain , 1997, Nature Medicine.
[133] C. J. Collins,et al. Involvement of the INK4a/Arf gene locus in senescence , 2003, Aging cell.
[134] Mitch Leslie,et al. The age of cancer. , 2006, Science of aging knowledge environment : SAGE KE.
[135] S. Lowe,et al. Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.
[136] M. Serrano,et al. Senescence in tumours: evidence from mice and humans , 2010, Nature Reviews Cancer.
[137] Motowo Nakajima,et al. Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[138] R. Weinberg,et al. When cells get stressed: an integrative view of cellular senescence. , 2004, The Journal of clinical investigation.
[139] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[140] J. Shay,et al. Hallmarks of senescence in carcinogenesis and cancer therapy , 2004, Oncogene.
[141] K. Tracey,et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.
[142] Patricia D. Castro,et al. Cellular senescence in the pathogenesis of benign prostatic hyperplasia , 2003, The Prostate.
[143] B. Vandenbunder,et al. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway , 2002, Oncogene.
[144] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[145] P. Fisher,et al. Human Polynucleotide Phosphorylase (hPNPaseold-35) , 2004, Cancer Research.
[146] P. Dhawan,et al. Role of CXCL1 in tumorigenesis of melanoma , 2002, Journal of leukocyte biology.